With thanks to the following companies and institutions for their unconditional support of the ISoP 2025 Annual Meeting
Diamond Sponsor
Gold Sponsors
AB Cube
Life Sciences Trusted Cloud Software
AB Cube is the developer of the most efficient drug safety database software for life sciences organizations – enabling effortless pharmacovigilance, materiovigilance, cosmetovigilance and nutrivigilance operations in one unified platform. Founded in 2006, Paris-based AB Cube pioneered the industry’s with the first SaaS vigilance application. Now with a presence in 43 countries and serving over 220 international clients, today pharmaceutical laboratories, CROs, academics and health authorities trust AB Cube’s best-in-class SafetyEasy® Suite to support their global Multivigilance needs at every scale.
AB Cube’s offering includes our intuitive SafetyEasy® Suite, a software composed of three solutions:
- IntakeEasy: A suite of automated Modules for Data Capture.
- SafetyEasy® Vigilance: A Multivigilance solution for Data Management.
- SafetyEasy® Business Intelligence: A dynamic scientific Data Analytics solution.
Beyond software, AB Cube provides a range of expert services, including training, quality & validation, project management, technical assistance and migration. This comprehensive support ensures that our partners can maximize the benefits of their solutions.
Come discover SafetyEasy® Suite, a pre-validated, agile and compliant solution for global life science companies, integrating intelligent automation to streamline day-to-day activities, reduce manual effort and accelerate reporting processes for safety teams.
MedDRA
Medical Dictionary for Regulatory Activities
In the late 1990s, the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) developed MedDRA, a rich and highly specific standardized medical terminology to facilitate sharing of regulatory information internationally for medical products used by humans. ICH’s powerful tool, MedDRA is available to all for use in the registration, documentation and safety monitoring of medical products both before and after a product has been authorized for sale. Products covered by the scope of MedDRA include pharmaceuticals, biologics, vaccines and drug-device combination products. Today, its growing use worldwide by regulatory authorities, pharmaceutical companies, clinical research organizations and health care professionals allows better global protection of patient health.
The Maintenance and Support Services Organization (MSSO) was established by the (ICH) to manage the Medical Dictionary for Regulatory Activities (MedDRA) terminology. The MSSO serves as the repository, maintainer, and distributor of MedDRA. In this capacity, the MSSO ensures that the integrity of the terminology, as well as its medical correctness, stay intact. The MSSO has maintained the Terminology in a state of control since its receipt of the “Golden Master” version of the terminology and several supporting documents in December 1998. This Quality System Manual (QSM) for the MSSO defines and describes program management responsibilities and MedDRA maintenance and support organization process and product baselines for the MSSO. This QSM provides overarching guidance for the operation and maintenance of the MedDRA Maintenance Quality Management System (QMS).
Nextrove
Nextrove is a global consulting and technology firm with deep-rooted expertise in pharmacovigilance system optimization and safety operations.
With decades of experience in the Life Sciences sector, our team delivers end-to-end solutions across the entire safety chain from implementation, upgrades, cloud hosting and data migration to regulatory intelligence.
We provide full-service support for leading PV platforms including validated migrations and complex system integrations. Our proprietary Progressive Suite extends core safety systems with interoperable modules that enable automation, case intake optimization, and advanced reporting capabilities.
As a trusted partner to top pharmaceutical companies, CROs, and biotechs, we combine technical depth with industry expertise to drive digital transformation and operational excellence, empowering pharma to improve patient safety.
https://www.linkedin.com/company/nextrove/
Eu2P
Eu2P stands for “European program in Pharmacovigilance and Pharmacoepidemiology“. This consortium, coordinated by the university of Bordeaux, offers an innovative and academic web-based education & training offer in Pharmacovigilance and Pharmacoepidemiology at the worldwide level:
- An accredited Master of Science program :
This curriculum includes mandatory and optional course modules, possibly leading to a Master Specialisation Track - 32 individual accredited Certificates courses :
They can be attended on a single basis during the Master curriculum calendar - 91 individual Short courses :
They are bite-sized courses which have been designed out of the Master and Certificate modules’ course material and can be attended at anytime, any-pace.
Eu2P has recently been extended to the Am2P program dedicated to North American stakeholders in collaboration to the NaSOP chapter. Am2P also provides accredited postgraduate certificates and short courses in Pharmacovigilance and Pharmacoepidemiology and can be attended online at anytime, any-pace.
More info at www.eu2p.org and www.am2p-courses.com
Media Partners
Springer Nature
Springer Nature advances discovery by publishing robust and insightful research, supporting the development of new areas of knowledge, making ideas and information accessible around the world, and leading the way on open access.
Key to this is our ability to provide the best possible service to the whole research community.
Springer Nature’s catalog offers a wide range of products and services, including AdisInsight Safety which equips you with the essential tools to seamlessly manage your in-house PV literature monitoring. Our cutting-edge platform empowers you to efficiently monitor Individual Case Safety Reports (ICSRs) for adverse events and special situations. Plus, you can stay up to date with the latest drug safety news, ensuring that your PV processes remain robust and compliant. And what’s more important, AdisInsight Safety covers all pharmaceutical products.
You can rely on Springer Nature’s extensive knowledge and expertise, earned over 40 years as an industry leader. Our experience gives us a unique perspective on the challenges you face today, helping you see the world of drug development more clearly.
